Mariya Balyura
Overview
Explore the profile of Mariya Balyura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balyura M, Gelfgat E, Steenblock C, Androutsellis-Theotokis A, Ruiz-Babot G, Guasti L, et al.
PLoS One
. 2018 Mar;
13(3):e0194643.
PMID: 29596439
Encapsulation of primary bovine adrenocortical cells in alginate is an efficacious model of a bioartificial adrenal cortex. Such a bioartificial adrenal cortex can be used for the restoration of lost...
2.
Ruiz-Babot G, Balyura M, Hadjidemetriou I, Ajodha S, Taylor D, Ghataore L, et al.
Cell Rep
. 2018 Feb;
22(5):1236-1249.
PMID: 29386111
Adrenal insufficiency is managed by hormone replacement therapy, which is far from optimal; the ability to generate functional steroidogenic cells would offer a unique opportunity for a curative approach to...
3.
Balyura M, Gelfgat E, Ullmann E, Ludwig B, Barnea E, Bornstein S
Horm Metab Res
. 2017 Oct;
50(2):168-174.
PMID: 29065432
The main treatment algorithm for adrenal insufficiency is hormonal replacement, however, inadequate hormone substitution often leads to severe side effects. Adrenal cell transplantation could be a more effective alternative but...
4.
Hofmann A, Brunssen C, Peitzsch M, Balyura M, Mittag J, Frenzel A, et al.
Horm Metab Res
. 2017 Apr;
49(6):466-471.
PMID: 28427090
Inhibition of aldosterone synthase is an alternative treatment option to mineralocorticoid receptor antagonism to prevent harmful aldosterone actions. FAD286 is one of the best characterized aldosterone synthase inhibitors to date....
5.
Balyura M, Gelfgat E, Ehrhart-Bornstein M, Ludwig B, Gendler Z, Barkai U, et al.
Proc Natl Acad Sci U S A
. 2015 Feb;
112(8):2527-32.
PMID: 25675525
Current treatment options for adrenal insufficiency are limited to corticosteroid replacement therapies. However, hormone therapy does not replicate circadian rhythms and has unpleasant side effects especially due to the failure...
6.
Hamann C, Picke A, Campbell G, Balyura M, Rauner M, Bernhardt R, et al.
Endocrinology
. 2014 Jan;
155(4):1197-206.
PMID: 24467747
Type 2 diabetes mellitus (T2DM) is associated with increased skeletal fragility and impaired fracture healing. Intermittent PTH therapy increases bone strength; however, its skeletal and metabolic effects in diabetes are...
7.
Ludwig B, Rotem A, Schmid J, Weir G, Colton C, Brendel M, et al.
Proc Natl Acad Sci U S A
. 2012 Mar;
109(13):5022-7.
PMID: 22393012
Islet transplantation is a feasible therapeutic alternative for metabolically labile patients with type 1 diabetes. The primary therapeutic target is stable glycemic control and prevention of complications associated with diabetes...